Trial intelligence / Profile preview

Role of Purinergic Compounds in the Vascular Pathology of Pseudoxanthoma Elasticum

NCT07323082Recruiting

Sponsor
Centre Hospitalier Universitaire de Nice
Start
Jan 2026
Primary completion
Jan 2027
Countries
1
01

Overview

Trial (2 arms), sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Potential role of the ADO. Started Jan 2026; status: recruiting.

Beyond the preview

Go deeper on NCT07323082.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07323082.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call